Decreased virulence of cystic fibrosis Pseudomonas aeruginosa in Dictyostelium discoideum

Microbiology and Immunology

Volumn 55, Issue 4, 2011, Pages 224-230

  Bradbury, Richard Stewart ^a   Reid, David William Edward Cochrane ^a,b   Inglis, Timothy John Jay ^c   Champion, Alan Charles ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Cystic fibrosis; Dictyostelium discoideum; Pseudomonas aeruginosa; Virulence

Indexed keywords

AZITHROMYCIN; CEFTAZIDIME;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTIC FIBROSIS; DICTYOSTELIUM DISCOIDEUM; ENVIRONMENT; HEAT SHOCK; HOSPITAL; HOST PATHOGEN INTERACTION; KLEBSIELLA AEROGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTOZOAN SPORE; PSEUDOMONAS AERUGINOSA;

BIOLOGICAL ASSAY; CYSTIC FIBROSIS; DICTYOSTELIUM; HUMANS; MODELS, BIOLOGICAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE;

DICTYOSTELIUM DISCOIDEUM; EUKARYOTA; PSEUDOMONAS AERUGINOSA;

EID: 79953124835     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00314.x     Document Type: Article

References (28)

1. Prithiviraj B., Bais H.P., Weir T., Suresh B., Najarro E.H., Dayakar B.V., Schweizer H.P., Vivanco J.M. (2005) Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans. Infect Immun 73: 5319-28.
2. Alibaud L., Köhler T., Coudray A., Prigent-Combaret C., Bergeret E., Perrin J., Benghezal M., Reimmann C., Gauthier Y., van Delden C., Attree I., Fauvarque M.O., Cosson P. (2008) Pseudomonas aeruginosa virulence genes identified in a Dictyostelium host model. Cellular Microbiol 10: 729-40.
3. Fenner L., Richet H., Raoult D., Papazian L., Martin C., La Scola B. (2006) Are clinical isolates of Pseudomonas aeruginosa more virulent than hospital environmental isolates in amoebal co-culture test? Crit Care Med 34: 823-8.
4. Matz C., Morena A.M., Alherde M., Manefield M., Hauser A.R., Givskov M., Kjelleberg S. (2008) Pseudomonas aeruginosa uses type III secretion system to kill biofilm associated amoebae. ISME J 2: 843-52.
5. Cosson P., Zulianello L., Join-Lambert O., Faurisson F., Gebbie L., Benghezal M., van Delden C., Curty L.K., Köhler, T. (2002) Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J Bacteriol 184: 3027-33.
6. Pukatzki S., Kessin R.H., Mekalanos J.J. (2002) The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc. Natl. Acad. Sci. USA 99: 3159-64.
7. Carilla-Latorre S., Calvo-Garrido J., Bloomfield G., Skelton J., Kay R.R., Ivens A., Martinez J.L., Escalante R. (2008) Dictyostelium transcriptional responses to Pseudomonas aeruginosa: common and specific effects from PAO1 and PA14 strains. BMC Microbiol 8: 109. doi:
8. Gross J. D. (1994) Developmental decisions in Dictyostelium discoideum. Microbiol Rev 58: 330-51.
9. Steinert M., Heuner K. (2005) Dictyostelium as a host model for pathogenesis. Cellular Microbiol 7: 307-14.
10. Parent C. A., Devreotes P.N. (1996) Molecular genetics of signal transduction in Dictyostelium. Ann Rev Biochem 65: 411-40.
11. Bradbury R., Champion A.C., Reid D.W. (2008) Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Respirology 13: 886-92.
12. Bradbury R. S., Champion A.C., Reid D.W. (2009) Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital. J Hosp Infect 73: 151-6.
13. Bradbury R.S., Roddam L.F, Merritt A., Reid D.W., Champion A.C. (2010) Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa. J Med Microbiol 59: 881-90.
14. Watts D.J., Ashworth J.M. (1970) Growth of myxamoebae of the cellular slime mould Dictyostelium discoideum in axenic culture. Biochem J 119: 171-4.
15. Williams K.L., Newell P.C. (1976) A genetic study of aggregation in the cellular slime mould Dictyostelium discoideum using complementation analysis. Genetics 82: 287-307.
16. Clinical Laboratory Standards Institute (2006) Performance Standards for Antimicrobial Susceptibility Testing. 19th informational supplement. M100-S19. Wikler M.A., ed. Wayne, PA: CLSI.
17. Tessin I., Thiringer K., Trollfors B., Brorson J.E. (1988) Comparison of serum concentrations of ceftazidime and tobramycin in newborn infants. Eur J Paediatr 147: 405-7.
18. Fleiss J.L. (1981) Statistical Methods for Rates and Proportions, 2nd edn. New York: John Wiley & Sons.
19. Anthony M., Rose B., Pegler M.B., Elkins M., Service H., Thamotharampillai K., Watson J., Robinson M., Bye P., Merlino J., Harbour C. (2002) Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J Clin Microbiol 40: 2772-8.
20. Filopon, D. Mérieau A., Bernot G., Comet J.P., Leberre R., Guery B., Polack B., Guespin-Michel J. (2006) Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa. BMC Bioinformatics 7: 272. doi:
21. Jain M., Ramirez D., Seshadri R., Cullina J.F., Powers C.A., Schulert G.S., Bar-Meir M., Sullivan C.L., McColley S.A., Hauser, A.R. (2004) Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J Clin Microbiol 42: 5229-37.
22. Roy-Burman A., Savel R.H., Racine S., Swanson B.L., Ravadigar N.S., Fujimoto J., Sawa T., Frank D.W., Weiner-Kronish J.P. (2001) Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 183: 1767-74.
23. Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D'Argenio D.A., Miller S.I., Ramsey B.W., Speert D.P., Moskowitz S.M., Burns J.L., Kaul R., Olson M.V. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. PNAS 22: 8487-92.
24. May T. B., Shinabarger D., Maharaj R., Kato J., Chu L., DeVault J.D., Roychoudhury S., Zielinski N.A., Berry A., Rothmel R.K., Misra T.K., Chakrabarty A.M. (1991) Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev 4: 191-206.
25. Nalca Y., Jansch L., Bredenbruch F., Geffers R., Buer J., Haussler S. (2007) Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 50: 1680-8.
26. -/- mice. Antimicrob Agents Chemother 51: 3677-87.
27. Tateda K., Ishii Y., Kimura S., Horikawa M., Miyairi S., Yamaguchi, K. (2007) Suppression of Pseudomonas aeruginosa quorum sensing systems by macrolides: a promising strategy or an oriental mystery? J Infect Chemother 13: 357-67.
28. Linares J.F., López J.A., Camafeita E., Albar J.P., Rojo F., Martínez, J.L. (2005) Overexpression of the multidrug efflux pumps MexCDOprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol 87: 1384-91.